+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Drug Sales Forecast - Q1, 2021

  • ID: 5305203
  • Report
  • March 2021
  • Region: Global
  • 41 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Arcturus Therapeutics Ltd
  • CTI BioPharma Corp
  • Enlivex Therapeutics Ltd
  • GlaxoSmithKline Plc
  • InflaRx NV
  • Pfizer Inc
  • MORE
Summary

This report contains a summary of the analyst consensus forecasts available in the publisher's Pharma Intelligence Center Drug Sales and Analyst Consensus Database for the Indication COVID-19. Currently there are 29 drugs indicated for COVID-19 which have analyst consensus forecasts available.

Scope

This 41-page report gives important, expert insight you won’t find in any other source. 14 figures throughout the report illustrate major points and trends in COVID sales forecasts and company pipelines. This report is required reading for -
  • Investors that want to understand how COVID-19 has impacted Drug Revenues in the biopharmaceutical industry as well as identifying companies to invest in
  • Companies that are interested in entering the COVID-19 disease space
  • Large pharma companies with investment groups or BD teams looking for partnership opportunities in the COVID-19 disease space
Reasons to Buy
  • Analysis of COVID-19 analyst consensus sales forecasts
  • Overview of Pipeline portfolio of companies involved in COVID-19 disease space
  • Detailed Analysis of how COVID-19 have affected analyst consensus sales forecasts for previously forecasted Drugs
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Arcturus Therapeutics Ltd
  • CTI BioPharma Corp
  • Enlivex Therapeutics Ltd
  • GlaxoSmithKline Plc
  • InflaRx NV
  • Pfizer Inc
  • MORE
1 COVID-19 Global Analyst Consensus Sales Forecast
1.1 COVID-19 Prophylactic Vaccines with Global Analyst Consensus Sales Forecast
1.2 COVID-19 Therapeutic Drugs with Global Analyst Consensus Sales Forecast
1.3 COVID-19 Global Analyst Consensus Sales Forecast
1.4 Top Three COVID-19 Drugs with Peak Forecast: Global Analyst Consensus Sales Forecast

2 COVID-19 Prophylactic Vaccine and Therapeutic Drugs: Global Analyst Consensus Sales Forecasts
2.1 COVID-19 Prophylactic Vaccine Global Analyst Consensus Sales Forecast
2.2 COVID-19 Therapeutic Drugs: Global Analyst Consensus Sales Forecast

3 BioNTech SE
3.1 Global Analyst Consensus Sales Forecast - Comirnaty
3.2 Percentage Change from Q4 2020 to Q1 2021 Global Analyst Consensus Sales Forecast- Comirnaty

4 Moderna
4.1 Global Analyst Consensus Sales Forecast - mRNA-1273
4.2 Percentage Change from Q4 2020 to Q1 2020 Global Analyst Consensus Sales Forecast - mRNA-1273

5 Novavax Inc
5.1 Global Analyst Consensus Sales Forecast - NVX-CoV2373

6 Inovio
6.1 Global Analyst Consensus Sales Forecast - INO-4800

7 Gilead Sciences
7.1 Global Analyst Consensus Sales Forecast - Veklury
7.2 Percentage Change from Q4 2029 to Q1 2020 Global Analyst Consensus Sales Forecast - Veklury

8 Key Findings

9 Appendix
9.1 Abbreviations
9.2 Methodology
9.3 Related Reports
9.4 About the Authors
9.5 About the Publisher
9.6 Contact
Note: Product cover images may vary from those shown
3 of 3
  • Arcturus Therapeutics Ltd
  • Atossa Therapeutics Inc
  • CanSino Biologics Inc
  • ContraFect Corp
  • CTI BioPharma Corp
  • CureVac NV
  • Dynavax Technologies Corp
  • Eiger BioPharmaceuticals Inc
  • Eli Lilly and Co
  • Enlivex Therapeutics Ltd
  • Evelo Biosciences Inc
  • Genexine Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Heat Biologics Inc
  • I-Mab
  • Immunome Inc
  • InflaRx NV
  • Inovio Pharmaceuticals Inc
  • Kiniksa Pharmaceuticals Ltd
  • Moderna Inc
  • Molecular Partners AG
  • Novavax Inc
  • Pfizer Inc
  • Regeneron Pharmaceuticals Inc
  • Shionogi & Co Ltd
  • TFF Pharmaceuticals Inc
  • Vir Biotechnology Inc
Note: Product cover images may vary from those shown
Adroll
adroll